content contributor jared schuster

Jared Schuster, BS, HTL(ASCP), CABP

NMDP

Jared has 12+ years experience in biotech within scientific, quality, and regulatory roles. At NMDP, he oversees regulatory CMC and strategy functions for cell & gene therapy programs, focusing on procurement of cellular starting materials. Formerly, he worked as a scientist at a CRO offering assay development and biomarker validation services under CLIA. His academic work at the University of Minnesota focused on development anti-inflammatory therapies for chronic viral infections. Jared is an active member of ASCP, AABB, RAPS, ASGCT and ISCT. He holds degrees in Molecular Genetics and Pharmacology, and is a certified Histotechnologist (ASCP) and Advanced Biotherapies Professional (AABB).

Browse This Author's Contributions

Regulation of Cell Therapy Products Regulation of Cell Therapy Products
New

Describes the regulatory framework and quality programs for HCT/Ps

two blood vials